AchievemenT of target resting HEart rate on beta-blockers in patients with stable angiNA and hypertension (ATHENA) in routine clinical practice in Russia

References

• World Health Organization (WHO). World Health Statistics. World Health Organization, Geneva. 2012. Available at: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf [Last accessed 25 June 2013]
   Google Scholar
• Nichols M, Townsend N, Luengo-Fernandez R, et al. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis. 2012. Available at: http://www.ehnheart.org/downloads/1365.html [Last accessed 25 June 2013]
   Google Scholar
• Petrukhin IS, Lunina EY. Cardiovascular disease risk factors and mortality in Russia: challenges and barriers. Public Health Reviews 2012;33:436-49
   Google Scholar
• Belenkov YN, Oganov RG. Cardiology: National Guidance. Moscow: Geotar-Media, 2008
   Google Scholar
• Oganov RG, Lepakhin VK, Fitilev SB, et al. Diagnosis and therapy of stable angina in the Russian Federation (Angina Treatment Pattern Survey). Cardiology 2003;43:9-15
   PubMedGoogle Scholar
• Campeau L. Letter: grading of angina pectoris. Circulation 1976;54:522-3
   PubMed Web of Science ®Google Scholar
• Escobar E. Hypertension and coronary heart disease. J Hum Hypertens 2002;16(Suppl 1):S61-3
   PubMedGoogle Scholar
• Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011;123:1737-44
   PubMed Web of Science ®Google Scholar
• Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45
   PubMed Web of Science ®Google Scholar
• Palatini P. Elevated heart rate: a ‘new’ cardiovascular risk factor? Prog Cardiovasc Dis 2009;52:1-5
   PubMed Web of Science ®Google Scholar
• Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007;28:3012-19
   PubMed Web of Science ®Google Scholar
• Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30
   PubMed Web of Science ®Google Scholar
• Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs 2006;66:133-44
   PubMed Web of Science ®Google Scholar
• Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. Hypertension 2011;58:745-50
   PubMed Web of Science ®Google Scholar
• Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006;24:603-10
   PubMed Web of Science ®Google Scholar
• Benetos A, Rudnichi A, Thomas F, et al. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 1999;33:44-52
   PubMed Web of Science ®Google Scholar
• Goldstein S. Beta-blocking drugs and coronary heart disease. Cardiovasc Drugs Ther 1997;11(Suppl 1):219-25
   PubMedGoogle Scholar
• Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164
   PubMed Web of Science ®Google Scholar
• Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81
   PubMed Web of Science ®Google Scholar
• Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006;174:1737-42
   PubMed Web of Science ®Google Scholar
• Daly CA, Clemens F, Sendon JL, et al. Inadequate control of heart rate in patients with stable angina: results from the European heart survey. Postgrad Med J 2010;86:212-17
   PubMed Web of Science ®Google Scholar
• Steg PG, Ferrari R, Ford I, et al. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS One 2012;7:e36284
   PubMed Web of Science ®Google Scholar
• National guidelines on stable angina diagnostic and treatment. Cardiovasc Ther Prev 2008;7(Suppl 4)
   Google Scholar
• Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009;18:308-47
   PubMed Web of Science ®Google Scholar
• Hypertension diagnostic and treatment. Russian guidelines. IV update. Syst Hypertens 2010;3:5-26
   Google Scholar
• Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002;106:43-9
   PubMed Web of Science ®Google Scholar
• Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008;372:817-21
   PubMed Web of Science ®Google Scholar
• Hsia J, Larson JC, Ockene JK, et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ 2009;338:b219
   PubMedGoogle Scholar
• von Arnim T. Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. J Am Coll Cardiol 1995;25:231-8
   PubMed Web of Science ®Google Scholar
• Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996;17:76-81
   PubMed Web of Science ®Google Scholar
• Tolpygina SN, Martsevich SY. Efficacy and safety of high doses of metoprolol XL/CR in stable ischemic coronary disease patients. Rational Pharmacother Cardiol 2008;5:46-52
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219
   PubMed Web of Science ®Google Scholar
• Popovich L, Potapchik E, Shishkin S, et al. Russian Federation. Health system review (Health Systems in Transition, Vol 13 No 7). 2011. Available at: http://www.euro.who.int/__data/assets/pdf_file/0006/157092/HiT-Russia_EN_web-with-links.pdf [Last accessed 25 June 2013]
   Google Scholar